QUOTE AND NEWS
FiercePharma  5 hrs ago  Comment 
A 10% revenue expansion in Novartis' generics unit Sandoz was one of the positives in the Swiss drugmaker's second quarter earnings, but it will not keep the drugmaker from closing three Sandoz plants next year and cutting about 770 jobs to...
newratings.com  Jul 23  Comment 
BASEL (dpa-AFX) - MorphoSys AG (MPSYY, MPSYF) announced Thursday that it has received a milestone payment from Swiss drug giant Novartis AG (NVS) in connection with the initiation of a Phase 1 clinical trial of a HuCAL antibody in the field of...
The Economic Times  Jul 22  Comment 
Drug firm Novartis India today reported six per cent fall in its standalone net profit at Rs 13.45 crore for the first quarter ended June 30, 2015.
Wall Street Journal  Jul 21  Comment 
An appeals court said Novartis could begin the first U.S. sales of a copycat biotech drug on Sept. 2, a key step in efforts to contain spending on high-cost therapies through lower-priced competition.
newratings.com  Jul 21  Comment 
BRUSSELS (dpa-AFX) - The Swiss stock market ended Tuesday's session in the red. The market has been rallying in recent days and reached a new intraday high for the year during yesterday's session. The weakness of today's session...
Forbes  Jul 21  Comment 
Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the Vanguard FTSE All-World ex-US ETF (VEU), which added 6,300,831 units, or a 2.1% increase week over week. Among the...
FiercePharma  Jul 21  Comment 
Worried that health insurers' urge to merge will put even more pressure on your prices? You're in good company. Novartis CEO Joe Jimenez agrees.




 

Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki